Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-25 @ 4:57 AM
NCT ID:
NCT00756418
Eligibility Criteria:
Inclusion Criteria:
* Pediatric Bronchial Asthma Patients Aged 6 To 14 Years (At The Beginning Of The Treatment Period)
* The Severity Must Be Mild, Moderate Or Severe, Persistent Bronchial Asthma
* The Patient Must Have Symptoms That Can Be Used As Efficacy Variables (Such As Repeated Coughing And Mild Or Moderate Asthma Attacks) During The Observation Period, And Must Be Using Inhaled Steroids
Exclusion Criteria:
* Patient Using Anti-Asthma Treatment Or Therapy Including corticosteroids Or Oral Anti-Allergic Drugs
* Patient With Complications That Will Impair The Judgment Of Efficacy Of This Drug
* Patient With Convulsive Disorders Such As Epilepsy Or Such A History
* Patient With Liver Disease, Renal Impairment, Heart Disease Or Such Other Complication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
14 Years
Study:
NCT00756418
Study Brief:
Protocol Section:
NCT00756418